Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia

    August 2014 in “ Dermatologic Therapy
    Andy Goren, Jerry Shapiro, Janet L. Roberts, John D. McCoy, Nisha Desai, Z Zarrab, Aldona Pietrzak, Torello Lotti
    Image of study
    TLDR Minoxidil response testing helps treat hair loss effectively and safely.
    The study confirms the clinical validity of minoxidil response testing in treating androgenetic alopecia (AGA) and demonstrates its clinical utility in guiding AGA treatment. The test could protect consumers from the potential side effects, emotional stress, and expense associated with the use of an ineffective drug. Minoxidil response testing could also direct patients to seek medical consultation earlier and ultimately improve outcomes for AGA patients.
    Discuss this study in the Community →

    Research cited in this study

    7 / 7 results

    Related Community Posts Join

    6 / 1000+ results

      community Story time! The Great Unbalding (PP405)

      in Research/Science  223 upvotes 1 week ago
      PP405 is a promising new hair loss treatment that may reactivate dormant hair follicles without side effects. It could surpass traditional treatments like minoxidil and finasteride if successful in further trials.

      community Not everyone should immediately go on Fin if they are starting to bald

      in Finasteride/Dutasteride  21 upvotes 1 year ago
      The conversation suggests that people should consult a dermatologist to understand their type of hair loss before starting treatments like finasteride or dutasteride, especially if they have autoimmune issues or low DHT. Some participants believe in starting treatment like finasteride immediately if hair loss is due to DHT, while others recommend ruling out other causes and considering minoxidil first, especially for younger individuals.

      community I am a dermatologist with a clinical interest in alopecia. AMA

      in Will treatment work for me? 3 years ago
      In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jak inhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.

    Related Research

    3 / 3 results